title: Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
abstract: In a total of 62 samples of cerebrospinal fluid (CSF) and an equal number of serum samples obtained from 16 patients suffering from amyotrophic lateral sclerosis, 22 patients suffering from miscellaneous neurological diseases, and 24 controls, lead was measured by atomic absorption spectrophotometry. No statistical difference in lead concentration was found between the above three groups.
authors.affiliation: Department of Neurology, Athens University, Aeginition Hospital, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Kapaki
authors.forename: J
authors.initials: J
authors.lastname: Segditsa
authors.forename: C
authors.initials: C
authors.lastname: Zournas
authors.forename: D
authors.initials: D
authors.lastname: Xenos
authors.forename: C
authors.initials: C
authors.lastname: Papageorgiou
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000097:blood / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D007854:Lead / Q000097:blood / Q000134:cerebrospinal fluid*; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000097:blood / Q000134:cerebrospinal fluid*; D012016:Reference Values; D013054:Spectrophotometry, Atomic
chemical_list: D007854:Lead